The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b trial of IFx-Hu2.0, a novel personalized cancer vaccine, in checkpoint inhibitor resistant Merkel cell carcinoma and cutaneous squamous cell carcinoma.
 
Andrew Scott Brohl
Consulting or Advisory Role - Bayer; Deciphera
Expert Testimony - GlaxoSmithKline (I)
 
Joseph Markowitz
Stock and Other Ownership Interests - Aflac; Amdocs; Consolidated Edison; CVS; Intel
Honoraria - Springer
Consulting or Advisory Role - Newlink Genetics
Research Funding - Idera (Inst); Jackson Laboratory for Genomic Medicine (Inst); Merck (Inst); Microba (Inst); Morphogenesis (Inst)
Patents, Royalties, Other Intellectual Property - Patent on development of Inhibitors for S100B (Inst); Pending patent on flow cytometry analysis system (Inst); Pending patent on the role of nitric oxide in melanoma. (Inst)
Other Relationship - Springer
 
Zeynep Eroglu
Consulting or Advisory Role - Eisai; Elsevier; Genentech/Roche; OncoSec; Pfizer; Regeneron
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst)
 
Ann W. Silk
Consulting or Advisory Role - Instil Bio; Signatera
Research Funding - Biohaven Pharmaceuticals (Inst); Checkmate Pharmaceuticals (Inst); Morphogenesis (Inst); Replimune (Inst); Shattuck Labs (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
John Robert Hyngstrom
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Checkmate Pharmaceuticals (Inst); Iovance Biotherapeutics (Inst); Lokon Pharma (Inst); Merck (Inst); Morphogenesis (Inst); oncosec (Inst); Philogen (Inst); Signatera (Inst); Skyline Diagnostics (Inst); Takara Bio (Inst)
 
Nikhil I. Khushalani
Stock and Other Ownership Interests - Amarin Corporation; Asensus Surgical; Bellicum Pharmaceuticals
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Castle Biosciences; Genzyme; Immunocore; Incyte; Instil Bio; Iovance Biotherapeutics; Jounce Therapeutics; Merck; NCCN/Pfizer; Nektar; Novartis; Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); HUYA Bioscience International (Inst); Merck (Inst); Modulation Therapeutics (Inst); Novartis (Inst); Regeneron (Inst); Replimune (Inst)
Other Relationship - Bristol-Myers Squibb/Celgene; Nektar; Regeneron; Replimune
 
Ahmad A. Tarhini
Consulting or Advisory Role - AstraZeneca; Bayer; BioNTech; Bristol-Myers Squibb; Clinigen Group; ConcertAI; Eisai; Genentech/Roche; Instil Bio; Merck; Novartis; Partner Therapeutics; Sanofi/Regeneron
Research Funding - Acrotech Biopharma (Inst); Agenus (Inst); Agenus (Inst); Bristol-Myers Squibb (Inst); Clinigen Group (Inst); Genentech/Roche (Inst); InflaRx (Inst); Merck (Inst); OncoSec (Inst); Pfizer (Inst); Sanofi/Regeneron (Inst); Scholar Rock (Inst)
 
Deanryan B. De-Aquino
No Relationships to Disclose
 
Edith Abraham
No Relationships to Disclose
 
Kenneth Yee Tsai
Consulting or Advisory Role - NFlection Therapeutics; Sun Pharma; Verrica Pharmaceuticals
 
Jacob Stephen Thomas
No Relationships to Disclose